Table of Content

1. Introduction



2. Research Methodology



3. Executive Summary



4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges


5. Global Hormone Replacement Therapy Market



6. Market Share
6.1 By Therapy Type
6.2 By Disease Type
6.3 By Route of Administration
6.4 By Distribution Channel
6.5 By Country


7. Therapy Type
7.1 Estrogen Hormone Replacement Therapy
7.2 Human Growth Hormone Replacement Therapy
7.3 Thyroid Hormone Replacement Therapy
7.4 Testosterone Hormone Replacement Therapy
7.5 Progestogen Hormone Replacement Therapy


8. Disease Type
8.1 Menopause
8.2 Hypothyroidism
8.3 Male Hypogonadism
8.4 Growth Hormone Deficiency
8.5 Others


9. Route of Administration
9.1 Oral
9.2 Parental
9.3 Others


10. Distribution Channel
10.1 Hospitals Pharmacies
10.2 Retail Pharmacies & Stores
10.3 Online Pharmacies


11. Country
11.1 North America

11.1.1 United States
11.1.2 Canada

11.2 Europe

11.2.1 France
11.2.2 Germany
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Belgium
11.2.7 Netherlands
11.2.8 Turkey

11.3 Asia Pacific

11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Thailand
11.3.6 Malaysia
11.3.7 Indonesia
11.3.8 Australia
11.3.9 New Zealand

11.4 Latin America

11.4.1 Brazil
11.4.2 Mexico
11.4.3 Argentina

11.5 Middle East & Africa

11.5.1 Saudi Arabia
11.5.2 UAE
11.5.3 South Africa


12. Porter’s Five Analysis
12.1 Bargaining Power of Buyers
12.2 Bargaining Power of Suppliers
12.3 Degree of Rivalry
12.4 Threat of New Entrants
12.5 Threat of Substitutes


13. SWOT Analysis
13.1 Strength
13.2 Weakness
13.3 Opportunity
13.4 Threat


14. Company Analysis
14.1 Abbott Laboratories

14.1.1 Company Overview
14.1.2 Product Portfolio
14.1.3 Recent Development
14.1.4 Financial Performance

14.2 Bayer AG

14.2.1 Company Overview
14.2.2 Product Portfolio
14.2.3 Recent Development
14.2.4 Financial Performance

14.3 Eli Lilly & Company

14.3.1 Company Overview
14.3.2 Product Portfolio
14.3.3 Recent Development
14.3.4 Financial Performance

14.4 Novartis AG

14.4.1 Company Overview
14.4.2 Product Portfolio
14.4.3 Recent Development
14.4.4 Financial Performance

14.5 Novo Nordisk A/S

14.5.1 Company Overview
14.5.2 Product Portfolio
14.5.3 Recent Development
14.5.4 Financial Performance

14.6 Pfizer Inc.

14.6.1 Company Overview
14.6.2 Product Portfolio
14.6.3 Recent Development
14.6.4 Financial Performance

14.7 Abbvie Inc. (Allergan plc)

14.7.1 Company Overview
14.7.2 Product Portfolio
14.7.3 Recent Development
14.7.4 Financial Performance

14.8 Teva Pharmaceutical Industries Ltd

14.8.1 Company Overview
14.8.2 Product Portfolio
14.8.3 Recent Development
14.8.4 Financial Performance

14.9 Dr. Reddy’s Laboratories Ltd

14.9.1 Company Overview
14.9.2 Product Portfolio
14.9.3 Recent Development
14.9.4 Financial Performance



List of Figures

0

List of Tables

0